Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 25,000 shares at $22.82 ($554K) on 2022-08-19, disclosed to the SEC on 2022-08-22.
Open-market sale of $554k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.54 | 10,000 | $225K | 40.7% |
| 2 | $22.82 | 8,700 | $199K | 35.8% |
| 3 | $20.71 | 6,300 | $130K | 23.5% |
| Total | $22.18 avg | 25,000 | $554K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |